155
Participants
Start Date
June 12, 2018
Primary Completion Date
October 8, 2020
Study Completion Date
September 14, 2021
BMS-986036
Specified dose on specified days.
Placebo
Specified dose on specified days.
Mount Sinai Hospital, New York
Local Institution - 0036, New York
Icahn School of Medicine at Mount Sinai, New York
Northwell Health, Manhasset
University at Buffalo, Buffalo
Local Institution - 0004, Pittsburgh
University of Pennsylvania, Philadelphia
Local Institution - 0009, Philadelphia
Local Institution, Washington D.C.
Gastroenterology Associates, PC, Manassas
The Gastroenterology Group, Reston
Local Institution - 0010, Baltimore
Local Institution - 0058, Catonsville
Inova Fairfax Hospital, Falls Church
University of Virginia Health System, Charlottesville
Bon Secours Liver Institute of Richmond, Richmond
Local Institution - 0077, Richmond
Local Institution - 0050, Richmond
Local Institution - 0069, Norfolk
Northeast GI Research Division, Concord
Local Institution - 0064, Charlotte
Local Institution - 0108, Marietta
Local Institution, Atlanta
Mayo Clinic - Jacksonville, Jacksonville
Local Institution - 0081, Orlando
Clinical Research of Homestead, Homestead
Local Institution - 0079, Coral Gables
Local Institution - 0003, Miami
A+ Research, Miami
IMIC Research, Miami
Top Medical Research, Cutler Bay
Local Institution, Tampa
Local Institution - 0001, Lakewood Rch
Sensible Healthcare, Ocoee
North Alabama Health Research, LLC, Madison
Local Institution - 0041, Hermitage
Local Institution, Chattanooga
Local Institution - 0046, Germantown
University of Michigan, Ann Arbor
Clinical Research Professionals, Chesterfield
Saint Louis University, St Louis
Local Institution - 0031, Kansas City
Tandem Clinical Research, Marrero
Tulane University Health Sciences Center, New Orleans
Local Institution - 0026, New Orleans
Local Institution - 0051, Dallas
Local Institution - 0053, Dallas
Texas Digestive Disease Consultants - Dallas, Dallas
University of Texas Southwestern Medical Center, Dallas
Texas Clinical Research Institute, Arlington
Local Institution - 0084, Fort Worth
Local Institution - 0002, Houston
Local Institution - 0057, Houston
Local Institution - 0063, Houston
Local Institution - 0028, San Antonio
Local Institution - 0011, San Antonio
Local Institution - 0102, San Antonio
Local Institution - 0066, Austin
Local Institution - 0088, Phoenix
Local Institution - 0006, Phoenix
Local Institution - 0005, Chandler
Local Institution - 0090, Tucson
Local Institution - 0017, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
Huntington Medical Research Institutes - HMRI Liver Center, Pasadena
Local Institution - 0020, Pasadena
Catalina Research Institute, Montclair
Local Institution - 0038, La Jolla
Local Institution, San Diego
Local Institution - 0092, Coronado
Local Institution - 0014, San Diego
Local Institution - 0012, Rialto
Local Institution - 0089, San Clemente
Kindred Medical Institute for Clinical Trials, Corona
Diverse Research Solutions, Oxnard
Local Institution - 0073, Redwood City
Local Institution - 0068, San Francisco
Kaiser Permanente, Oakland
Keio University Hospital, Shinjuku-ku
Local Institution - 0072, Kashihara
Kurume University Hospital, Kurume
GastroIntestinal Biosciences, Los Angeles
Local Institution - 0042, Bridgeport
Boston Medical Center, Boston
NECCR PrimaCare Research, Fall River
Local Institution - 0067, Butner
Vanderbilt University Medical Center, Nashville
University of Vermont Medical Center, Burlington
Local Institution - 0055, Yokohama
Toranomon Hospital, Minato
Fukushima Medical University Hospital, Fukushima
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY